Biofrontera BFRI Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Rises Purple Innovation PRPL Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid Revenue Disclosures PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility IMKTA Q1 2026 Earnings Strong EPS Performance Despite Modest Market Reaction OSBC Q1 2026 Earnings EPS Falls Short of Expectations as Revenue Details Remain Undisclosed